Light-based therapy reduces pain associated with peripheral diabetic neuropathy, study concludes
A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...
EurekAlert!5d
Light-based therapy reduces pain associated with peripheral diabetic neuropathy, study proves
The study was conducted at the Federal University of São Paulo and involved 144 diabetic patients, who were treated with ...
GlobalData on MSN9d
Averitas completes recruitment for trial of QUTENZA to treat post-surgical pain
Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...
verywellhealth1d
When Should You Worry About Calf Pain? (and What to Do Next)
If you experience severe or sudden calf pain or suddenly have trouble moving or walking, it’s time to contact a healthcare ...
Knowridge2d
New light therapy offers hope for diabetic nerve pain relief
A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...
pressat11d
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
With our current indications, adults with painful diabetic peripheral neuropathy of the feet and postherpetic neuralgia, we have advanced the trajectory of QUTENZA ® in the U.S. by expanding access to ...
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA
QUTENZA is a topical system, non-systemic, non-opioid pain treatment that is currently approved in the US for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and ...
Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript
Operator Good day, and welcome to the Vertex Pharmaceuticals third quarter 2024 earnings call. All participants will be in a ...